| RS74091614 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Acute myeloid leukemia |
| RS74103423 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 2 |
| RS74114618 |
CASQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 2 |
| RS74116308 |
CELSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS74124661 |
NDUFS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS74128547 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia 2, Inborn genetic diseases |
| RS74136386 |
PKP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS74141466 |
CTNNA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 13, Arrhythmogenic right ventricular dysplasia 13 |
| RS74142901 |
DNAJC12
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphenylalaninemia due to DNAJC12 deficiency, Hyperphenylalaninemia due to DNAJC12 deficiency |
| RS74157365 |
STN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebroretinal microangiopathy with calcifications and cysts 2, STN1-related disorder |
| RS74160617 |
FGFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Coronal Synostosis, Craniosynostosis syndrome |
| RS74162061 |
AIRE
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyglandular autoimmune syndrome, type 1 |
| RS74162067 |
FOXP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Inborn genetic diseases |
| RS74162074 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS74162075 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS74162084 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS74162087 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS74162090 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS74162093 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS74162097 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Malignant tumor of esophagus |
| RS74162102 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Inborn genetic diseases |
| RS74173201 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS7418956 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS74253369 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS74282951 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, Seckel syndrome 1 |
| RS74315103 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS74315109 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS74315110 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS74315111 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS74315130 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS74315144 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS74315146 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, mild |
| RS74315152 |
ABCC6
|
Health Risk |
Likely pathogenic |
Autosomal recessive inherited pseudoxanthoma elasticum, Autosomal recessive inherited pseudoxanthoma elasticum |
| RS74315154 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS74315205 |
WFS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Wolfram-like syndrome, Autosomal dominant nonsyndromic hearing loss 6 |
| RS74315270 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS74315271 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS74315277 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS74315280 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS74315283 |
AGT
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS74315284 |
BSND
|
Health Risk |
Pathogenic |
Bartter disease type 4A, Bartter disease type 4A |
| RS74315285 |
BSND
|
Health Risk |
Pathogenic |
Bartter disease type 4A, Bartter syndrome |
| RS74315286 |
BSND
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 4A, Bartter syndrome |
| RS74315287 |
BSND
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 4A, Bartter syndrome |
| RS74315288 |
BSND
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 4A, Bartter syndrome type 4 |
| RS74315289 |
BSND
|
Health Risk |
Pathogenic/Likely pathogenic |
Bartter disease type 4A, Bartter syndrome |
| RS74315290 |
CD247
|
Health Risk |
Pathogenic |
Immunodeficiency 25, Immunodeficiency 25 |
| RS74315291 |
CHRNB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 3, Autosomal dominant nocturnal frontal lobe epilepsy 3 |
| RS74315293 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase II deficiency, severe infantile form |
| RS74315294 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, myopathic form |
| RS74315295 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, myopathic form |
| RS74315296 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, myopathic form |
| RS74315297 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity; other |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS74315298 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, neonatal form |
| RS74315299 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase II deficiency, myopathic form |
| RS74315300 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase II deficiency, myopathic form |
| RS74315301 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS74315302 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Inborn genetic diseases |
| RS74315303 |
CTSK
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS74315304 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS74315305 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS74315306 |
CTSK
|
Health Risk |
Pathogenic |
Pyknodysostosis, Pyknodysostosis |
| RS74315309 |
EDARADD
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type |
| RS74315311 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, See cases |
| RS74315312 |
GJC2
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS74315313 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS74315314 |
GJC2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS74315315 |
GJB3
|
Health Risk |
Likely pathogenic |
Erythrokeratodermia variabilis et progressiva 1, Erythrokeratodermia variabilis et progressiva 1 |
| RS74315316 |
GJB3
|
Health Risk |
Pathogenic |
Erythrokeratodermia variabilis et progressiva 1, Erythrokeratodermia variabilis et progressiva 1 |
| RS74315317 |
GJB3
|
Health Risk |
Pathogenic |
Erythrokeratodermia variabilis et progressiva 1, Erythrokeratodermia variabilis et progressiva 1 |
| RS74315318 |
GJB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 2B, Erythrokeratodermia variabilis et progressiva 1 |
| RS74315321 |
GJB3
|
Health Risk |
Pathogenic |
Erythrokeratodermia variabilis et progressiva 1, Erythrokeratodermia variabilis et progressiva 1 |
| RS74315322 |
HAX1
|
Health Risk |
Pathogenic |
Kostmann syndrome, Kostmann syndrome |
| RS74315323 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 1, Hemochromatosis type 2A |
| RS74315324 |
HJV
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS74315325 |
HJV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS74315326 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, Hemochromatosis type 2A |
| RS74315327 |
HJV
|
Health Risk |
Pathogenic |
Hemochromatosis type 2A, HJV-related disorder |
| RS74315328 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315329 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315330 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315331 |
MYOC
|
Health Risk |
Likely pathogenic |
Glaucoma 1, open angle |
| RS74315332 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315334 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315336 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315338 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315341 |
MYOC
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS74315342 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS74315343 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS74315344 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS74315345 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS74315346 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS74315347 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS74315348 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS74315349 |
NR0B2
|
Health Risk |
Pathogenic |
Obesity, mild |
| RS74315351 |
PARK7
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 7, Autosomal recessive early-onset Parkinson disease 7 |
| RS74315353 |
PARK7
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 7, Autosomal recessive early-onset Parkinson disease 7 |
| RS74315355 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS74315356 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS74315357 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |